Effects of deranged metabolism on epigenetic changes in cancer
Explore this paper's citation graph
Summary
The impacts of metabolic changes on cancer epigenetics are discussed, along with the current knowledge on cancer metabolism and epigenetics.
- Type
- article
- Published
- 2015-01-29
- Cited by
- 11
- References
- 221
- Access
- Open access
- OpenAlex
- https://openalex.org/W25628247
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:21603831
Keywords
Liability, Property (philosophy), Real property, Business, Law and economics
References
- Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis
- A microRNA DNA methylation signature for human cancer metastasis
- Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism.
- Daily sodium butyrate enema for the prevention of radiation proctitis in prostate cancer patients undergoing radical radiation therapy: results of a multicenter randomized placebo-controlled dose-finding phase 2 study.
- DNA methyltransferases as targets for cancer therapy.
- The Citric Acid Cycle Is a Source of Biosynthetic Precursors
- Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions.
- Coenzyme A function in and acetyl transfer by the phosphotransacetylase system.
- Chemoprevention of hepatocarcinogenesis: S-adenosyl-L-methionine.
- [Clinical trial on the effects of shikonin mixture on later stage lung cancer].
- DNA Methyltransferases (DNMTs), DNA Damage Repair, and Cancer
- Molecular mechanisms of metabolic reprogramming in proliferating cells: implications for T‐cell‐mediated immunity
- Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain
- Catalysis of methyl group transfers involving tetrahydrofolate and B(12).
- Oncogenes in Tumor Metabolism, Tumorigenesis, and Apoptosis
- EGCG, GREEN TEA POLYPHENOLS AND THEIR SYNTHETIC ANALOGS AND PRODRUGS FOR HUMAN CANCER PREVENTION AND TREATMENT
- An emerging role of mTOR in lipid biosynthesis
- Sulforaphane and related mustard oils in focus of cancer prevention and therapy
- Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins
- Mutagen sensitivity and suppression of position‐effect variegation result from mutations in mus209, the Drosophila gene encoding PCNA.
Cited by
- Targeting cancer cells with oleanolic and ursolic acid derived hydroxamates.
- MicroRNA aberrations: An emerging field for gallbladder cancer management.
- Glutamine activates STAT3 to control cancer cell proliferation independently of glutamine metabolism
- L-securinine inhibits the proliferation of A549 lung cancer cells and promotes DKK1 promoter methylation.
- Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer
- Application of CRISPR/Cas9 gene editing technique in the study of cancer treatment
- Nanoplasmonic sensing of NADH by inhibiting the oxidative etching of gold nanorods
- ApcMin/+ tumours and normal mouse small intestines show linear metabolite concentration and DNA cytosine hydroxymethylation gradients from pylorus to colon
- Metaboloepigenetics in cancer, immunity, and cardiovascular disease
- Toward a Mechanistic Understanding of Poly- and Perfluoroalkylated Substances and Cancer
- securinine inhibits the proliferation of A 549 lung cancer cells and promotes DKK 1 promoter methylation
Related papers
- A Vision and Problem of the Making a Liability Theory for an Environmental Damage
- Efficiency of liability rules: A reconsideration
- Research on orientation of the guarantee liability about blemish in Chinese
- A Study on Presumption of Casual Relationship and No-Fault Liability in the Liability for Compensation of the Business Owner in accordance with the Act on Liability for Environmental Damage and Relief Thereof
- Interpretation to Fair Liability of The Tort Liability Act
- On Liability to Pay Compensation for Breach of Contract
- Constructing Our Country's Indemnity System of Product Liability Punitive Damages